COVID-19: Pfizer jab recipients have lower antibodies targeting Indian variant, study suggests
People who have received the Pfizer/BioNTech vaccine have fewer antibodies targeting the Indian COVID-19 variant compared to other strains, new data suggests.
United Kingdom City Of Eleanor Riley Committee On Vaccination National Virology Consortium Virus Threats Advisory Group Nervtag
Source: originalfm.com